A detailed history of Hills Bank & Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Hills Bank & Trust CO holds 3,745 shares of LLY stock, worth $2.88 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
3,745
Previous 3,385 10.64%
Holding current value
$2.88 Million
Previous $3.06 Million 8.26%
% of portfolio
0.26%
Previous 0.26%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$772.14 - $960.02 $277,970 - $345,607
360 Added 10.64%
3,745 $3.32 Million
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $29,719 - $37,270
41 Added 1.23%
3,385 $3.06 Million
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $117,847 - $157,663
199 Added 6.33%
3,344 $2.6 Million
Q4 2023

Feb 07, 2024

SELL
$525.19 - $619.13 $120,268 - $141,780
-229 Reduced 6.79%
3,145 $1.83 Million
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $396,011 - $545,962
-911 Reduced 21.26%
3,374 $1.81 Million
Q2 2023

Jul 21, 2023

SELL
$350.74 - $468.98 $122,057 - $163,205
-348 Reduced 7.51%
4,285 $2.01 Million
Q1 2023

Apr 17, 2023

SELL
$310.63 - $364.82 $182,339 - $214,149
-587 Reduced 11.25%
4,633 $1.59 Million
Q4 2022

Feb 06, 2023

SELL
$321.55 - $374.67 $227,335 - $264,891
-707 Reduced 11.93%
5,220 $1.91 Million
Q3 2022

Nov 03, 2022

SELL
$296.48 - $337.87 $340,062 - $387,536
-1,147 Reduced 16.21%
5,927 $1.92 Million
Q2 2022

Aug 02, 2022

SELL
$278.73 - $327.27 $218,245 - $256,252
-783 Reduced 9.97%
7,074 $2.29 Million
Q1 2022

Apr 29, 2022

BUY
$234.69 - $291.66 $7,040 - $8,749
30 Added 0.38%
7,857 $2.25 Million
Q4 2021

Feb 04, 2022

BUY
$224.85 - $279.04 $53,064 - $65,853
236 Added 3.11%
7,827 $2.16 Million
Q3 2021

Oct 27, 2021

BUY
$221.6 - $272.71 $132,516 - $163,080
598 Added 8.55%
7,591 $1.75 Million
Q2 2021

Aug 02, 2021

BUY
$180.55 - $233.54 $5,777 - $7,473
32 Added 0.46%
6,993 $1.61 Million
Q1 2021

May 03, 2021

BUY
$164.32 - $212.72 $30,070 - $38,927
183 Added 2.7%
6,961 $1.3 Million
Q4 2020

Feb 01, 2021

BUY
$130.46 - $172.63 $59,881 - $79,237
459 Added 7.26%
6,778 $1.14 Million
Q3 2020

Oct 27, 2020

BUY
$146.22 - $169.13 $194,472 - $224,942
1,330 Added 26.66%
6,319 $935,000
Q2 2020

Aug 05, 2020

BUY
$136.42 - $164.18 $46,382 - $55,821
340 Added 7.31%
4,989 $819,000
Q1 2020

Apr 17, 2020

BUY
$119.05 - $147.35 $104,406 - $129,225
877 Added 23.25%
4,649 $645,000
Q4 2019

Jan 27, 2020

BUY
$106.92 - $132.43 $63,617 - $78,795
595 Added 18.73%
3,772 $496,000
Q3 2019

Oct 18, 2019

BUY
$106.79 - $116.16 $127,507 - $138,695
1,194 Added 60.21%
3,177 $355,000
Q2 2019

Jul 16, 2019

BUY
$110.79 - $129.32 $17,394 - $20,303
157 Added 8.6%
1,983 $220,000
Q4 2018

Jan 28, 2019

BUY
$105.9 - $118.64 $193,373 - $216,636
1,826 New
1,826 $212,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hills Bank & Trust CO Portfolio

Follow Hills Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hills Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Hills Bank & Trust CO with notifications on news.